PerkinElmer Genetics will provide clinical whole-genome sequencing, data interpretation, and diagnostic reports to IDG for patients with neurological disorders.
A study focused on rare CNVs unearthed a subset of Tourette cases affected by deletions in the NRXN1 gene or duplications in the CNTN6 gene.
The pediatric health system will use RPRD's pharmacogenomics testing platform in its cancer and blood disorder clinic and its neurology/psychology practice.
Metagenomic sequencing may be a good tool to improve the diagnostic rate because it is such a broad approach and does not require "guessing" at the potential pathogen.
Researchers identified Neanderthal alleles associated with human conditions using genotypic and phenotypic information in health records for more than 28,000 individuals.
The results showed that syndromic forms of autism are more likely when children have alterations of genes in the mGluR pathway.
The life sciences company can now offer its genetic tests in all 50 states in the US, as well as Canada and several other countries.
TwoXar will use the funds to expand its engineering and commercial teams and support partnerships focused on drug candidates for metabolic and neurological diseases.
The company's platform offers space and computational tools for exploring, sharing, and storing genomic data in the context of genetic disorders.
Amarantus will use the investment to develop and commercialize its neurology diagnostic products and drug candidates, and for other working capital expenses.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.